• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Government shutdown could force FDA to cut staff

Government shutdown could force FDA to cut staff

April 8, 2011
CenterWatch Staff

Officials working with the FDA warned that the looming government shutdown will severely restrict food and drug inspections, according to a CNN Money report.

"We will be pretty severely limited. We're hopeful that a resolution is reached before it comes to that," an official said.

The FDA, an agency within the Department of Health and Human Services, consists of nine centers and offices and employs 13,000 workers.  However, the number of employees who would be unemployed as a result of a shutdown remains questionable.

If a shutdown occurs, the agency's Office of Regulatory Affairs, which oversees food inspections, won't operate at full capacity but will have some inspectors on staff.

Because of this, all FDA inspections of food processing facilities and drug manufacturing plants must focus on risk. That means that high-risk inspections of plants that have a history of serious safety concerns will be a priority over routine plant inspections.

If an emergency situation arises, such as a food-borne illness outbreak, the FDA will be able to call furloughed staff to return to work.

The FDA's current effort to monitor for radiation in food products coming from Japan—and for higher radiation levels in existing food products already in the market—will not be affected by staffing shortages.

However, the FDA will not conduct specific inspections of drug or medical device manufacturing facilities that are required when a manufacturer files for a new product application with the agency.

The FDA's other centers, including the Center for Biologic Evaluation, the Center for Veterinary Medicine and the Center for Medical Devices and Radiological Health will also operate at reduced capacity.

Of the agency's nine centers, only the Center for Tobacco Products, which employs 275 workers, will remain fully staffed in the event of a shutdown. That's because it is funded by the tobacco industry.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing